Chimeric Antigen Receptor T-Cell Therapy in Metastatic Castrate-Resistant Prostate Cancer

SIMPLE SUMMARY: Prostate cancer is one of the most frequently diagnosed cancers amongst men worldwide. Treatment for metastatic disease is often in the form of androgen deprivation therapy. However, over the course of treatment affected men may become castrate-resistant. Options for men with metasta...

Descripción completa

Detalles Bibliográficos
Autores principales: Perera, Mahasha P.J., Thomas, Patrick B., Risbridger, Gail P., Taylor, Renea, Azad, Arun, Hofman, Michael S., Williams, Elizabeth D., Vela, Ian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8833489/
https://www.ncbi.nlm.nih.gov/pubmed/35158771
http://dx.doi.org/10.3390/cancers14030503

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8833489/
https://www.ncbi.nlm.nih.gov/pubmed/35158771
http://dx.doi.org/10.3390/cancers14030503

Ejemplares similares